Contrasting Merit Medical Systems (NASDAQ:MMSI) & Vivos Therapeutics (NASDAQ:VVOS)

Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) and Merit Medical Systems (NASDAQ:MMSI – Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations and institutional ownership.

Earnings & Valuation

This table compares Vivos Therapeutics and Merit Medical Systems”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Vivos Therapeutics $17.44 million 0.11 -$21.17 million ($1.90) -0.05
Merit Medical Systems $1.61 billion 3.22 $128.49 million $2.66 32.57

Merit Medical Systems has higher revenue and earnings than Vivos Therapeutics. Vivos Therapeutics is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

26.4% of Vivos Therapeutics shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 1.4% of Vivos Therapeutics shares are owned by insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Vivos Therapeutics and Merit Medical Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Vivos Therapeutics -122.00% -2,325.64% -102.01%
Merit Medical Systems 9.94% 14.12% 8.37%

Volatility and Risk

Vivos Therapeutics has a beta of 6.37, suggesting that its share price is 537% more volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Vivos Therapeutics and Merit Medical Systems, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vivos Therapeutics 1 1 2 0 2.25
Merit Medical Systems 0 5 8 0 2.62

Vivos Therapeutics currently has a consensus price target of $2.80, suggesting a potential upside of 2,757.14%. Merit Medical Systems has a consensus price target of $105.55, suggesting a potential upside of 21.83%. Given Vivos Therapeutics’ higher probable upside, equities analysts plainly believe Vivos Therapeutics is more favorable than Merit Medical Systems.

Summary

Merit Medical Systems beats Vivos Therapeutics on 11 of the 14 factors compared between the two stocks.

About Vivos Therapeutics

(Get Free Report)

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing oral appliances and related treatments for sleep-disordered breathing, including obstructive sleep apnea (OSA) and snoring. Its approach is designed to help improve upper-airway function through non-surgical, dentist-supervised therapies. The company’s primary products are its Vivos Complete Airway Repositioning and Expansion (CARE) oral appliances, which are customized for individual patients and intended for use during sleep.

About Merit Medical Systems

(Get Free Report)

Merit Medical Systems develops, manufactures and markets medical devices used in diagnostic and interventional procedures. Its products support clinicians in areas including cardiology, radiology, oncology and endoscopy. The company’s portfolio includes devices and accessories for vascular access, diagnostic and therapeutic procedures, drainage, biopsy and embolization. Merit serves hospitals, clinics and other healthcare providers through direct sales and distribution channels. Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves customers in the United States and internationally.

Receive News & Ratings for Vivos Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivos Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.